Capri Global Capital Limited (BOM:531595)
India · Delayed Price · Currency is INR 186.65
-3.45 (-1.81%)
At close: Aug 5, 2025
Inozyme Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Net Income | - | 4,785 | 2,794 | 2,047 | 2,050 | 1,770 | Upgrade |
Depreciation & Amortization | - | 776.54 | 792.65 | 403.87 | 79.14 | 84.43 | Upgrade |
Other Amortization | - | 240.59 | 86.05 | 35.26 | 19.63 | 20.68 | Upgrade |
Loss (Gain) From Sale of Investments | - | -1,284 | -508.93 | -119.64 | 650.22 | 318.78 | Upgrade |
Asset Writedown & Restructuring Costs | - | 6.43 | 2.55 | 1.75 | - | - | Upgrade |
Stock-Based Compensation | - | 91.63 | 85.7 | 141.75 | 54.78 | 25.45 | Upgrade |
Change in Accounts Payable | - | 152.56 | 410.47 | 699.35 | 261.31 | 3.03 | Upgrade |
Change in Other Net Operating Assets | - | -47,373 | -39,604 | -32,836 | -16,057 | -5,606 | Upgrade |
Other Operating Activities | - | -510.95 | -1,039 | -430.54 | -457.98 | 197.84 | Upgrade |
Operating Cash Flow | - | -43,116 | -36,986 | -30,069 | -13,401 | -3,186 | Upgrade |
Capital Expenditures | - | -654.26 | -635.75 | -1,186 | -106.55 | -64.25 | Upgrade |
Sale of Property, Plant & Equipment | - | 2.89 | 73.31 | 1.41 | 3.98 | 2.73 | Upgrade |
Cash Acquisitions | - | - | - | 207.77 | - | - | Upgrade |
Sale (Purchase) of Intangibles | - | 160.85 | -42.33 | -124.83 | -11.7 | 1.28 | Upgrade |
Investment in Securities | - | 1,488 | 404.96 | 1,630 | 3,040 | -4,179 | Upgrade |
Other Investing Activities | - | -396.62 | 129.31 | 114.81 | 235.15 | -416.32 | Upgrade |
Investing Cash Flow | - | 600.48 | -70.5 | 654.02 | 3,165 | -4,653 | Upgrade |
Short-Term Debt Issued | - | 145.13 | 3,151 | - | 654.26 | - | Upgrade |
Long-Term Debt Issued | - | 97,080 | 57,087 | 40,518 | 18,640 | 20,060 | Upgrade |
Total Debt Issued | - | 97,225 | 60,238 | 40,518 | 19,294 | 20,060 | Upgrade |
Short-Term Debt Repaid | - | - | - | -58.05 | - | - | Upgrade |
Long-Term Debt Repaid | - | -45,590 | -31,088 | -13,630 | -8,965 | -11,099 | Upgrade |
Total Debt Repaid | - | -45,590 | -31,088 | -13,688 | -8,965 | -11,099 | Upgrade |
Net Debt Issued (Repaid) | - | 51,635 | 29,150 | 26,830 | 10,330 | 8,961 | Upgrade |
Issuance of Common Stock | - | 6.63 | 11.74 | 14,353 | 1,522 | 21.09 | Upgrade |
Common Dividends Paid | - | -123.74 | -103.08 | -79.83 | -70.14 | -35.04 | Upgrade |
Other Financing Activities | - | -332.86 | -371.41 | -147.62 | -26.11 | -25.56 | Upgrade |
Financing Cash Flow | - | 51,185 | 28,688 | 40,955 | 11,755 | 8,922 | Upgrade |
Net Cash Flow | - | 8,669 | -8,369 | 11,540 | 1,519 | 1,083 | Upgrade |
Free Cash Flow | - | -43,771 | -37,621 | -31,255 | -13,508 | -3,250 | Upgrade |
Free Cash Flow Margin | - | -243.52% | -281.71% | -376.30% | -259.78% | -75.33% | Upgrade |
Free Cash Flow Per Share | - | -52.78 | -45.24 | -38.79 | -19.04 | -4.60 | Upgrade |
Cash Interest Paid | - | 12,954 | 8,793 | 5,525 | 3,461 | 25.56 | Upgrade |
Cash Income Tax Paid | - | 1,467 | 1,148 | 844.63 | 922.41 | 652.48 | Upgrade |
Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.